Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 7,574Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5Actavis Inc

02 8Ajanta Pharma Limited

03 4Apotex Inc

04 2Ascent Pharmaceuticals

05 3Aurolife Pharma LLC

06 1Barr Laboratories

07 4Farbe Firma

08 2Fresenius Kabi Austria

09 7Fresenius Kabi USA

10 3GL Pharma

11 4Genus Lifesciences

12 4HAMELN PHARMA PTY. LTD.

13 3Hana Pharm

14 9Hikma Pharmaceuticals

15 7Hospira, Inc.

16 1JAMP PHARMA

17 5Janssen-Cilag

18 5Johnson & Johnson Innovative Medicine

19 4Juno Pharmaceuticals Pty Ltd

20 2Lannett Company, Inc.

21 3Link Healthcare

22 15Mallinckrodt Pharmaceuticals

23 10Medsurge Healthcare

24 49Mundipharma

25 3Nesher Pharmaceuticals USA LLC

26 1Nostrum Laboratories

27 5Osmotica Pharmaceuticals

28 4Padagis

29 1Pfizer Inc

30 11Pharmascience Inc.

31 12Purdue Pharma

32 4Purdue Pharmaceuticals L.P

33 4RHODES PHARMACEUTICALS LP

34 2Rising Pharmaceuticals Inc

35 4STERIMAX INC

36 5Sandoz B2B

37 2Sterinova Inc.

38 1Streuli Pharma

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

HYDROMORPHONE HYDROCHLORIDE

Brand Name : HYDROMORPHONE HYDROCHLORIDE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 10MG/ML

Packaging :

Approval Date : 1995-08-23

Application Number : 74317

Regulatory Info : DISCN

Registration Country : USA

blank

02

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

HYDROMORPHONE HYDROCHLORIDE

Brand Name : HYDROMORPHONE HYDROCHLORIDE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 10MG/ML

Packaging :

Approval Date : 2003-04-25

Application Number : 76444

Regulatory Info : DISCN

Registration Country : USA

blank

03

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

HYDROMORPHONE HYDROCHLORIDE

Brand Name : DILAUDID-HP

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 10MG/ML

Packaging :

Approval Date : 1984-01-11

Application Number : 19034

Regulatory Info : DISCN

Registration Country : USA

blank

04

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

HYDROMORPHONE HYDROCHLORIDE

Brand Name : DILAUDID-HP

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 250MG/VIAL

Packaging :

Approval Date : 1994-08-04

Application Number : 19034

Regulatory Info : DISCN

Registration Country : USA

blank

05

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

HYDROMORPHONE HYDROCHLORIDE

Brand Name : DILAUDID

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 1MG/ML

Packaging :

Approval Date : 2009-04-30

Application Number : 19034

Regulatory Info : RX

Registration Country : USA

blank

06

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

HYDROMORPHONE HYDROCHLORIDE

Brand Name : DILAUDID

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 2MG/ML

Packaging :

Approval Date : 2009-04-30

Application Number : 19034

Regulatory Info : RX

Registration Country : USA

blank

07

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

HYDROMORPHONE HYDROCHLORIDE

Brand Name : DILAUDID

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 4MG/ML

Packaging :

Approval Date : 2009-04-30

Application Number : 19034

Regulatory Info : RX

Registration Country : USA

blank

08

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

HYDROMORPHONE HYDROCHLORIDE

Brand Name : DILAUDID

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 0.2MG/ML

Packaging :

Approval Date : 2020-01-16

Application Number : 19034

Regulatory Info : RX

Registration Country : USA

blank

09

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

HYDROMORPHONE HYDROCHLORIDE

Brand Name : DILAUDID

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 0.5MG/0.5ML

Packaging :

Approval Date : 2017-02-10

Application Number : 19034

Regulatory Info : RX

Registration Country : USA

blank

10

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

HYDROMORPHONE HYDROCHLORIDE

Brand Name : HYDROMORPHONE HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : 8MG

Packaging :

Approval Date : 1998-07-29

Application Number : 74597

Regulatory Info : DISCN

Registration Country : USA

blank

11

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

HYDROMORPHONE HYDROCHLORIDE

Brand Name : HYDROMORPHONE HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : 4MG

Packaging :

Approval Date : 2009-05-29

Application Number : 74597

Regulatory Info : DISCN

Registration Country : USA

blank

12

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

HYDROMORPHONE HYDROCHLORIDE

Brand Name : HYDROMORPHONE HYDROCHLORIDE

Dosage Form : SOLUTION;ORAL

Dosage Strength : 5MG/5ML

Packaging :

Approval Date : 1998-07-29

Application Number : 74653

Regulatory Info : RX

Registration Country : USA

blank

13

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

HYDROMORPHONE HYDROCHLORIDE

Brand Name : HYDROMORPHONE HYDROCHLORIDE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 10MG/ML

Packaging :

Approval Date : 1997-06-19

Application Number : 74598

Regulatory Info : DISCN

Registration Country : USA

blank

14

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

HYDROMORPHONE HYDROCHLORIDE

Brand Name : EXALGO

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 2010-03-01

Application Number : 21217

Regulatory Info : DISCN

Registration Country : USA

blank

15

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

HYDROMORPHONE HYDROCHLORIDE

Brand Name : EXALGO

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 12MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 2010-03-01

Application Number : 21217

Regulatory Info : DISCN

Registration Country : USA

blank

16

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

HYDROMORPHONE HYDROCHLORIDE

Brand Name : EXALGO

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 16MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 2010-03-01

Application Number : 21217

Regulatory Info : DISCN

Registration Country : USA

blank

17

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

HYDROMORPHONE HYDROCHLORIDE

Brand Name : EXALGO

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 32MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 2012-08-24

Application Number : 21217

Regulatory Info : DISCN

Registration Country : USA

blank

18

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

HYDROMORPHONE HYDROCHLORIDE

Brand Name : HYDROMORPHONE HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : 8MG

Packaging :

Approval Date : 2004-12-23

Application Number : 76855

Regulatory Info : RX

Registration Country : USA

blank

19

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

HYDROMORPHONE HYDROCHLORIDE

Brand Name : HYDROMORPHONE HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : 2MG

Packaging :

Approval Date : 2007-09-19

Application Number : 76855

Regulatory Info : RX

Registration Country : USA

blank

20

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

HYDROMORPHONE HYDROCHLORIDE

Brand Name : HYDROMORPHONE HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : 4MG

Packaging :

Approval Date : 2007-09-19

Application Number : 76855

Regulatory Info : RX

Registration Country : USA

blank

21

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

HYDROMORPHONE HYDROCHLORIDE

Brand Name : HYDROMORPHONE HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : 2MG

Packaging :

Approval Date : 2005-11-09

Application Number : 77311

Regulatory Info : DISCN

Registration Country : USA

blank

22

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

HYDROMORPHONE HYDROCHLORIDE

Brand Name : HYDROMORPHONE HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : 8MG

Packaging :

Approval Date : 2005-10-18

Application Number : 76723

Regulatory Info : DISCN

Registration Country : USA

blank

23

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

HYDROMORPHONE HYDROCHLORIDE

Brand Name : PALLADONE

Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL

Dosage Strength : 12MG

Packaging :

Approval Date : 2004-09-24

Application Number : 21044

Regulatory Info : DISCN

Registration Country : USA

blank

24

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

HYDROMORPHONE HYDROCHLORIDE

Brand Name : PALLADONE

Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL

Dosage Strength : 16MG

Packaging :

Approval Date : 2004-09-24

Application Number : 21044

Regulatory Info : DISCN

Registration Country : USA

blank

25

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

HYDROMORPHONE HYDROCHLORIDE

Brand Name : PALLADONE

Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL

Dosage Strength : 24MG

Packaging :

Approval Date : 2004-09-24

Application Number : 21044

Regulatory Info : DISCN

Registration Country : USA

blank

26

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

HYDROMORPHONE HYDROCHLORIDE

Brand Name : PALLADONE

Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL

Dosage Strength : 32MG

Packaging :

Approval Date : 2004-09-24

Application Number : 21044

Regulatory Info : DISCN

Registration Country : USA

blank

27

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

HYDROMORPHONE HYDROCHLORIDE

Brand Name : DILAUDID

Dosage Form : SOLUTION;ORAL

Dosage Strength : 5MG/5ML

Packaging :

Approval Date : 1992-12-07

Application Number : 19891

Regulatory Info : RX

Registration Country : USA

blank

28

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

HYDROMORPHONE HYDROCHLORIDE

Brand Name : DILAUDID

Dosage Form : TABLET;ORAL

Dosage Strength : 8MG

Packaging :

Approval Date : 1992-12-07

Application Number : 19892

Regulatory Info : RX

Registration Country : USA

blank

29

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

HYDROMORPHONE HYDROCHLORIDE

Brand Name : DILAUDID

Dosage Form : TABLET;ORAL

Dosage Strength : 4MG

Packaging :

Approval Date : 2007-11-09

Application Number : 19892

Regulatory Info : RX

Registration Country : USA

blank

30

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

HYDROMORPHONE HYDROCHLORIDE

Brand Name : DILAUDID

Dosage Form : TABLET;ORAL

Dosage Strength : 2MG

Packaging :

Approval Date : 2007-11-09

Application Number : 19892

Regulatory Info : RX

Registration Country : USA

blank